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Marine organisms and microorganisms are known to be a rich source of alkaloids with unique chemical 
feature and interesting biological activities. The current study presents the antibacterial effect of the 
alkaloid extracts of some green, red and brown algae were collected from western coast of Libya, 
against, Escherichia coli, Salmonella typhi, Klebsiella spp., and Pseudomonas aeruginosa, 
Staphylococcus aureus, Bacillus subtilis, Bacillus spp. and Staphylococcus epidermidis were 
investigated. Although alkaloid extracts of green algae inhibited all tested bacteria, maximum effect was 
exhibited by brown and red algae species. Thus, Cystoseira barbata alkaloid extract showed remarkable 
inhibition of human pathogen Klebsiella spp. Dictyopteris membranacea alkaloid extract also 
demonstrated similar considerable effect against S. typhi with MIC value 1.56 mg/ml. The pronounced 
antibacterial activity of C. barbata and D. membranacea can be attributed to their high alkaloid contents. 
These results suggest that red and brown algae secondary metabolites are important sources that 
could produce potential chemotherapeutic agents. 
 





Algae are a large and diverse group of organisms from 
which a wide range of secondary metabolites have been 
isolated. A number of these compounds possess biolo-
gical activities such as toxicity, antibacterial, antifungal, 
antiviral, antitumour and other specific activity (Cannell, 
1993). These bioactive compounds include alkaloids 
(Guven et al., 2010), polyphenols) Pereira et al., 2002), 
terpenoids (Cen-Pacheco et al., 2010), flavonoids 
(Stafford, 1991), tannins (Serrano et al., 2009) and aceto-
genins (Narkowicz and Blackman, 2006) which are appli-
cable  for  antioxidant  (Rocha et al., 2007),  antimicrobial 
(Li, 2009; Saidani et al., 2011), antiviral (Romanos et al., 
2002; Mayer et al., 2009), anti-inflam-matory and 
anticancer activities (Jaswir and Monsur, 2011; Bhakuni 
and Rawat, 2005; Vasanthi et al., 2004; Natarajan and 
Kathiresan, 2010). Nevertheless, in Libya this kind of 
study has not been well explored, despite the wealth of 
Libyan marine flora. Therefore, the present study is to 
investigate the alkaloid compounds extracted from 
macro-algae from the Libyan coast. 
Alkaloids are heterocyclic nitrogen compounds, natu-
rally occurring in plants, microbes, animals and marine
 









organisms. The first medically useful example of an 
alkaloid was morphine, isolated in 1805 from opium 
papaver somniferum (Fessenden and Fessenden, 1982). 
Although, alkaloids have been extensively studied in 
plants and few studies in marine algae are reported due 
to the fact that alkaloids of marine algae are relatively 
rare compared with terrestrial plant alkaloids (Guven et 
al., 2010). The alkaloids found in marine algae can be 
classified into three groups: Phenylethylamine alkaloids, 
indole and halogenated indole alkaloids, and other alka-
loids. Structurally, phenylethylamine and indole groups 
are the most alkaloids isolated from marine algae. Bio-
logical activities of halogenated and non-halogenated 
forms have been reported as bioactive compounds and 
as biological probes for physiological studies (Kasim et 
al., 2010). In addition, Caulerpin isolated from macro-
algae, was the only indole alkaloid from marine sources 
which has been reported to have anti-inflammatory 
potentials (Carolina et al., 2011; Everton et al., 2009). In 
addition, there are two derivatives: lophocladine A and 
lophocladine B which have been isolated from a red alga 
Lophocladia spp., collected from Fijian Island, New 
Zealand (Gross et al., 2006) and their anticancer activity 
has been proved successfully in various cancer cell lines 
(Patricia et al., 2010). 
Previous studies revealed that seaweed extracts, 
especially polyphenols have antioxidant activity (Chandini 
et al., 2008; Ganesan et al., 2008); whereas alkaloids are 
commonly found to have antimicrobial properties against 
both Gram-positive and Gram-negative bacteria (Guven 
et al., 2010)
 
such as halogenated indole alkaloids which 
are isolated from red algae (Ayyad and Badria, 1994). 
These compounds have been approved for their antibac-
terial activity (Guella et al., 2006). The biological activity 
of marine indole alkaloids is clearly a product of the 
unique functionality and elements involved in the biosyn-
thesis of marine natural products which increase the 
biological activity of seaweeds. For instance, bromination 
of many natural products has the potential to increase 
biological activity significantly (Gul and Hamann, 2005). 
The current study was undertaken to investigate the 
antibacterial effect of alkaloid extracts of 6 species of 
marine algae (two Chlorophyceae, three Phaeophyceae 
and one Rhodophyceae) collected from the Libyan 
western coast, against pathogenic Gram-negative bacteria: 
Escherichia coli, Salmonella typhi, Klebsiella spp., and 
Pseudomonas aeruginosa as well as Gram positive bac-
teria, Staphylococcus aureus, Bacillus subtilis, Bacillus 
spp., and Staphylococcus epidermidis. 
 
 




Ulva lactuca, Codium tomentosum (Chlorophyta), Cystoseira 
barbata, Sargassum vulgare, Dictyopteris membranacea 
(Phaeophyta) and Gelidium latifolium (Rhodophyta) were collected 
from western coast of Libya between February and spring, 2009.  




The algal samples were taxonomically identified at Botany Depart-
ment, Faculty of Science, Tripoli University. Algae were washed 
properly with distilled water, then they were shade dried at room 
temperature, after which they were crushed in an electric mill until a 





Eight bacterial strains (Gram positive and negative) were selected 
for the study. The Gram positive species were: S. aureus (S. aur) 
was obtained from the Clinical Microbiology Laboratory, Azzawiya 
Medical Center (Azzawiya, Libya). B. subtilis (B. sub) were kindly 
provided by Mohamed Elghazali, Department of Microbiology 
Biotechnology Research Center (Twaisha, Libya), while Bacillus 
spp. (B. spp.) and S. epidermidis (S. epi) were obtained from the 
Department of Microbiology, Faculty of Veterinary Medicine, Tripoli 
University. The Gram negative species S. typhi (S. typhi), E. coli (E. 
coli), P. aeruginosa (P. aer) and klebsiella spp. (K. spp.) were 
obtained from the Department of Microbiology, Faculty of Veterinary 





Powdered algae materials (50 g) were extracted several times with 
methanol (300 ml). Methanol extraction was continued until the 
plant material gave a negative result for alkaloids (Mayer’s test). 
The obtained methanolic extract was evaporated under reduced 
pressure at 40°C, to minimize any possible thermal degradation of 
the alkaloids and other thermo labile compounds. The crude alka-
loid mixture was then separated from neutral and acidic materials, 
and water soluble ingredients by extraction with aqueous acetic 
acid, followed by dichloromethane extraction, then basification of 
the aqueous solution which was subjected to further dichloro-
methane extraction thereafter (Hadi and Bremner, 2001). 
 
 
Thin layer chromatography (TLC) 
 
Identification of alkaloids was further carried out by TLC using pre-
coated silica gel 60 F264 plates (Wagner and Bladt, 2004). 
Different screening systems were used to obtain better resolution of 
the components. Dragendorff’s reagent was used as a locating 
reagent (Harborne, 1992). Rf value of each spot was calculated as 




Determination of antibacterial activity 
 
The antimicrobial activity test of algal crude extracts was performed 
in vitro using the “hole-plate diffusion method” (Sarvanakumar et 
al., 2009). Each test organism was maintained on nutrient agar 
slant and was recovered for testing by growth in nutrient broth 
(Biolab, Difco) for 14 h at 37°C before streaking. Cultures were rou-
tinely adjusted to a suspension of 1 × 10
6
 to 2 × 10
6
 CFU/ml using 
pre-made calibration curve representing viable cell count (X × 10
6
) 
against OD 660 nm (Y). The plates with bacteria were incubated at 
37°C for 24 h. After incubation, the inhibition zones formed around 
the holes were measured. Methanol (100%) without seaweed 
extract was used as negative control and ciprofloxacin disc (30 μg) 
was used as the positive control. 
 
 
Determination of minimum inhibitory concentration (MIC) 
 
The MICs were determined by the agar dilution method (Daud and
 






Figure 1. Percentage of alkaloid yield (mg alkaloid/g dry weigh) extracted from U. lactuca, C. 




Sanchaz, 2005). Two-fold serial dilutions of the original algae 
extract (100 mg/ml) were prepared in nutrient broth to obtain 
concentration from 100 to 1.56 mg/ml solvent. The plates incubated 





Ten microliter (10 μl) of solutions corresponding to 1000 μg of 
alkaloids extract were applied to precoated Silica-gel TLC plates, 
developed with CHCl3/ MeOH/ Na2CO3 (3:8:1, v/v) for each extract, 
and was evaporated to complete dryness. The dried plates were 
overlaid with nutrient agar medium seeded with E. coli (106 to 107 





All assays were done in triplicate. All data are expressed as means 
± S.D. Data were analyzed by an analysis of variance (P < 0.05) 
and the means separated by one-way ANOVA with Turkey’s b test 
using SPSS version 20.0. 
 
 
RESULTS AND DISCUSSION 
 
The qualitative phytochemical analysis for U. lactuca, C. 
barbata, D. membranacea, C. tomentosum, S. vulgare 
and G. latifolium showed the presence of alkaloids accor-
ding to previous finding (Alghazeer et al., 2013). The 
present study was performed in order to extract alkaloids 
from the same species and then assess their antibacterial 
activity. Figure 1 shows alkaloid contents (% mg/g) 
extracted from green, red and brown algae species. The 
highest content was recorded for D. Membranacea 
(6.11%), S. vulgare (5.84%), U. lactuca (5.33%), (6.11%); 
whereas C. barbata and C. tomentosum showed mode-
rate content of alkaloid (3.2 and 2.84%, respectively), 
while the lowest alkaloid content was obtained from G. 
latifolium (2.37%). Alkaloids present special interest 
because of their pharmacological activities. In fact, many 
reports revealed the presence of alkaloids in marine 
algae and some of them have been investigated for their 
biological activity (Guven et al., 2010; Kasım et al., 2010). 
Antimicrobial activities of alkaloid extracts from six 
seaweeds species represented by three Phaeophyta (S. 
vulgare, D. membranacea and C. barbata), two Chloro-
phyta (U. lactuca and C. tomentosum) and one Rhodo-
phyta (G. latifolium) were examined against eight test 
bacteria (Bacillus spp., B. subtilis, S. aureus, S. epidermidis, 
E. coli, kleb. spp., P. aeruginosa and Salmonella typhi). 
The inhibition zones of brown, green and red algae 
extracts against Gram positive and Gram negative bacte-
ria ranged between 13 to 35, 12 to 29 and 15 to 34 mm, 
respectively, all values are shown in Table 1. 
The alkaloid extract of U. lactuca showed a relatively 
high mean zone of inhibition (21 ±  0.11 mm) against the 
Gram positive S. aureus, S. epidermis then Bacillus spp. 
(17 ± 0.3 mm), E. coli (16 ± 0.12 mm) and B. subtilis (14 
± 0.10 mm). While the alkaloid extract of C. tomentosum 
showed a remarkable high inhibition zone against S. 
epidermis (29 ± 0.35 mm) then Bacillus spp. (20 ± 0.3 
mm), S. aureus (16 ± 11) and B. subtilis (13 ± 0.09 mm). 
For Gram negative bacteria, maximum zone of inhibition 
was recorded with alkaloid extract of U. lactuca against 
kleb spp. (18 ± 0.15 mm) and S. typhi (17 ± 0.11 mm). 
Also, maximum inhibition zones were recorded by C. 
tomentosum alkaloid extract against klebsiella spp. (27 ± 
0.35 mm) then E. coli (23 ± 0.11 mm), S. typhi (21 ± 0.23 
mm) and P. aeruginosa (12 ± 0.09 mm) (Table 1). The 
alkaloid extract of S. vulgare and C. barbata showed 
highest mean zone of inhibition against the Gram positive
 
 




Table 1. In vitro antimicrobial activity of the algal alkaloids extracts (100 mg/ml) against gram positive and gram negative bacteria. 
 







Test organism DIZ (mm) DIZ (mm) DIZ (mm) DIZ (mm) DIZ (mm) DIZ (mm) DIZ (mm) DIZ (mm) DIZ(mm) 




 22±0.22 23 19 - 
S. typhi 17±0.11 21±0.23 18±0.11 25±0.6 35±0.74
*
 26±0.45 26 21 - 
Kleb. sp 18±0.15 27±0.35
*




 24 18 - 
P. aer 15±0.12 12±0.09 ND ND ND ND 20 - - 
B. sub 14±0.10 13±0.09 ND ND 23±0.6 15±0.12 29 - 21 
B. sp 17±0.11 20±0.35 24±0.11 19±0.21 ND 31±0.15
*
 24 - 26 
S. aur 21±0.15 16±0.11 15±0.12 13±0.09 16±0.11 22±0.15 25 - 20 




 18±0.11 23±0.15 20±0.11 23 - 23 
 
Data are expressed as the mean ± standard deviation (SD) of three replicates. * represent the statistical comparisons between alkaloid extracts and positive control by using ANOVA 




Bacillus spp. (19 ± 0.21 mm and 31 ± 0.15 mm, 
respectively) then against S. epidermis (18 ± 0.11; 
20 ± 0.11 mm, respectively), and S. aureus (13 ± 
0.09; 22 ± 0.15). However, D. membranacea 
alkaloid extract had no effect on Bacillus spp., but 
showed high inhibition zones against B. subtilis 
and S. epidermis (23 ± 0.6 and 23 ± 0.15 mm). 
Maximum inhibition zone of Gram negative bac-
teria was recorded for alkaloid extract of S. 
vulgare and D. membranacea against S. typhi (25 
± 0.6 mm; 35 ± 0.74 mm) while the highest effect 
by the alkaloid extract of C. barbata was observed 
against klebsiella spp. (35 ± 0.54 mm). Whereas, 
P. aeruginosa was not susceptible to the alkaloid 
extracts of S. vulgare, D. membranacea and C. 
barbata. 
The antibacterial activity of the alkaloid extract 
of D. membranacea and C. barbata were signi-
ficantly high (P<0.05) compared with the positive 
control (Ciprofloxacin and Chloramphenicol) against 
Gram negative bacteria (Table 1), the antibacterial 
activity of green, brown and red algae is well 
documented (Del Val et al., 2001) as well as their 
isolated alkaloids (Masuda et al., 1997; Kasim et 
al., 2010). The alkaloid extract of G. latifolium 
showed significant high mean zone of inhibition 
against the Gram positive S. epidermis (34 ± 0.6 
mm) compared with positive control (Ciprofloxacin 
and Neomycin) (P<0.05) which is in consistent 
with earlier finding where alkaloid isolated from 
red algae exhibited different modes of bioactivity 
(Sato et al., 1998; Gross et al., 2006). The recor-
ded inhibition zone against Bacillus spp. and S. 
aureus were 24 ± 0.11 and 15 ± 0.12 mm res-
pectively, while no inhibition was observed against 
B. subtilis. For Gram negative bacteria, maximum 
zone of inhibition was recorded with alkaloid 
extract of G. latifolium against E. coli (29 ± 0.54 
mm), S. typhi (18 ± 0.11 mm) and Kleb. sp. (15 ± 
0.11 mm), while no inhibition was observed 
against P. aeruginosa (Table 1). The activity of 
red, green and brown algae against both Gram 
positive and Gram negative bacteria may be indi-
cative of presence of broad spectrum antibiotic 
compounds or simply the content of pharmacolo--
gical active constituents like alkaloids (Omulokoli 
et al., 1997; Phang et al., 1994). 
Minimum inhibitory concentrations (MICs) of the  
alkaloid extracted from algae (Figure 2) were found 
to be within the range of 100 to 1.56 mg/ml. The 
high levels of the MIC's of some alkaloid extracts 
can be attributed either to the presence of the 
active components in low concentrations, or to the 
presence of some antagonistic components that 
serve as growth promoters for the bacteria. The 
minimum inhibitory concentration (MIC) value of 
green algae (U. lactuca, C. tomentosum) against 
bacteria was ranged between 6.25 to 100 mg/ml. 
The lowest MIC value was recorded for C. 
tomentosum and U. lactuca extracts (6.25, 25 
mg/ml respectively) against S. epidermidis while 
The minimum inhibitory concentration (MIC) value 
of brown algae (S. vulgare, D. membranacea and 
C. barbata) against bacteria was ranged between 
6.25 to 100 mg/ml. The lowest MIC (1.56, 6.25 
and 12.5 mg/ml) values were recorded for C. 
barbata, D. membranacea and S. vulgare ex-
tracts, respectively against klebsiella spp. (Figure 
1). For alkaloid extracted from red algae (G. 
latifolium), the minimum inhibitory concentration 
(MIC) values of brown algae (S. vulgare, D. 
membranacea and C. barbata) against bacteria were
 






Figure 2. The in vitro antimicrobial activity of alkaloids extracts of tested algae expressed as minimum inhibitory 
concentration (MIC) (mg/ml) against some bacteria. S. aur: Staphylococcus aureus, B. sub: Bacillus subtilis, E. coli: 
Escherichia coli, P. aer: Pseudomonas aeruginosa, B. sp: Bacillus spp., S. typhi: Salmonella typhi, S. epi: 




Table 2. Location and prominence of zones of inhibition at different Rf values 




S1  S2  S3 
Rf E. coli  Rf E. coli  Rf E. coli 
U. lactuca 0.57 +  0.68 +  - - 
C. tomentosum 0.59 -  0.72 +  - - 
G. latifolium 0.57 ++  0.61 -  0.68 + 
S. vulgare 0.55 +  0.76 +  - - 
D. membranacea 0.54 ++  0.64 -  0.75 ++ 
C. barbata 0.52 +  0.74 ++  - - 
 
Degree of inhibition: ++ = Prominent; + = moderate; - = Nil, E. coli: Escherichia coli; 




ranged between 1.56 to 100 mg/ml. The lowest MIC (1.56 
mg/ml) value was recorded against kleb. sp (Figure 1). 
Preliminary TLC and the bioautographic assay tests 
were carried out on extracts to separate the compounds 
that were responsible for the inhibition tested the bacteria 
hence one spot may contain more than one compound. 
The results showed that the antibacterial assay can be 
attributed to the compounds observed at the various Rf 
values on the TLC separation. Although, sometimes the 
activity of compounds is not easily detected by this 
assay, if the compound does not diffuse through the agar, 
then the activity could be masked. The bioautoghraphy 
method was applied to the extracts using E. coli isolate to 
which all extracts exhibited antimicrobial activity (Table 
1). The results showed good activity against E. coli, with 
prominent inhibition zones for the alkaloid of D. 
membranacea, C. barbata, S. vulgare, G. latifolium and 
U. lactuca extracts had two zones of inhibition, whereas, 
the alkaloid of C. tomentosum extract exhibited one zone 





The results of this work indicate the presence of alkaloids 
in tested algae that play an indispensable role in anti-
bacterial activity, however further studies to identify and 
characterize the specific active compounds, as well as 
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